Business Context and Reporting Period
Company: Apyx Medical Corporation
Filing Type: Form 8-K (Current Report)
Date: January 13, 2025
Reporting Period: Fourth quarter and full year ended December 31, 2024
Context: The filing announces the issuance of a press release containing preliminary revenue results for the specified periods.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing serves as a notification that preliminary revenue results have been released but does not list the figures within the 8-K body text itself.
Material Changes
No specific material changes or comparative data versus prior periods are detailed in this document. The filing references an external press release (Exhibit 99.1) for the actual results.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release on January 13, 2025, regarding preliminary revenue results.
Legal Disclaimer: The information furnished pursuant to Item 2.02 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. The report is not an admission as to the materiality of any information contained herein.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 13, 2025) for specific preliminary revenue figures.
- Verify the final audited financial statements for the fourth quarter and full year 2024 when the 10-Q or 10-K is filed.
- Confirm if the preliminary results include any restatements or adjustments to prior periods.